drug · antibody
benralizumab
pre_registrationupdated 3mo agoby $AZN ASTRAZENECA PLC🔗 ChEMBL
community read0 votes
🐶 often sniffed alongside
top 2Antibody drug with a maximum clinical stage of Approval (across all indications), with an approval for asthma and airway obstruction and 12 investigational indications.
indications
indications
Asthma
targets
Interleukin-5 receptor subunit alpha
all catalysts(0)
nothing on the calendar yet
Trials studying benralizumab
- —This is a Non-interventional, Study to Assess Demographic Characteristics and Patient Reported Outcomes in China Patients With SEA Treated With Benralizumab
- N/ACT Air-trapping for the Early Identification of Benralizumab Responders Among Eosinophilic Asthma Patients
- —A Real-life Observational Study in Severe Eosinophilic Asthma Adult Participant Treated With Benralizumab in Italy
- phase2Interest of a Targeted Therapy for the Treatment of a Severe Form of Hypersensitivity to Drug (DRESS Syndrome)
- phase3A Multicentre, Randomised, Double-blind, Parallel Group, Placebo-controlled, Time-to-first Asthma Exacerbation Phase III Efficacy and Safety Study of Benralizumab in Paediatric Patients With Severe Eosinophilic Asthma (DOMINICA)
- phase4Benralizumab Airway Remodeling Study in Severe Eosinophilic Asthmatics
- phase3STEP: Phase IIIb Study of Benralizumab to Step-down Maintenance Therapy in Patients With Severe Eosinophilic Asthma
- phase3A Trial to Investigate Benralizumab in Children With Eosinophilic Diseases
News(0)
no news has mentioned this drug yet
Data sources
last refreshed 43m ago
Found something off?
comments(0)
5-min edit window · permanent after that